Global Topical Pain Management Therapeutics in Sports Medicine Market Predicted to Expand at a Robust CAGR of 8.9% during 2017-2025

Published on : Feb 15, 2018

Albany, New York, February 15, 2018: A new study, offering holistic view of the pain management therapeutics in sports medicine market by performing extensive research on this emerging healthcare field and its present scenario across the globe has been added to the broad database of Market Research Hub (MRH). The comprehensive research study is titled as “Topical Pain Management Therapeutics in Sports Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 – 2025”, which imitates various analytics associated with the market across important geographies by carrying out an in-depth market segmentation with the help of which future projections are, five years down the line from 2017-2025, are drawn that can assist the reader in making informed decisions. The report also focuses on developments, trends, drivers and product innovations influencing the growth of the global topical pain management therapeutics in sport medicine market in the coming years.

Key Highlights

Sports medicine refer to to the treatment and prevention of injuries resulting from sports and athletic activities. In this scenario, topical pain management therapeutics are used which are specialty products and used to relieve acute musculoskeletal pain or general sprains or anxieties. Presently, in response to the rising sports activities around the world, the cases of sports injuries has augmented subsequently creating an environment conducive to the market’s evolution. As per the study evaluations, the global topical pain management therapeutics in sports medicine market is witnessing a significant growth and is expected to expand at considerable CAGR of 8.9% during the forecast period of 2017–2025. Also, the global market valuation to reach US$2.97 bn by the end of 2025, which stood at US$1.4 bn in 2016.

In a bid to offer detailed insights to readers, the report has divided global market analysis into various segments which are based on product type, therapeutic class, and geography. The geographical segmentation of the report highlights market growth scenario in regions such as Europe, Latin America, Asia Pacific, North America, and MEA. On the basis of product type, it covers gels, cream, sprays and patches. Of these, the gel segment is anticipated to hold a significant share of the global market.

It has been analyzed that these pain relievers are becoming increasingly popular in sports category owing to their site-specific action, cost-effectiveness and instant pain relief feature. Based on therapeutic class, the analgesics segment is likely to exhibit strong growth boosted by the rising demand for therapeutic treatment among patients.

Further, the report also examines the competition landscape in the global market and profiles some of the key players in this market in terms of company overview, company financials, strategy and recent developments. Key players are Mayne Pharma Group Limited, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Johnson & Johnson Services, Inc., Hisamitsu Pharmaceutical Co., Inc., GlaxoSmithKline plc, Endo Pharmaceuticals Inc., Beiersdorf AG, and Topical BioMedics, Inc.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top